search
Back to results

Intervention for Comorbid Substance Use and Bipolar Disorders (ITAP)

Primary Purpose

Bipolar Disorder, Substance Use Disorders

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Integrated Treatment Adherence Program (ITAP)
Safety Assessment and Follow-up Evaluation (SAFE)
Sponsored by
Butler Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bipolar Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion:

  • Diagnosis of a bipolar-spectrum disorder
  • Diagnosis of a substance use disorder
  • Taking at least one mood-stabilizing medication

Exclusion:

  • Unable to speak and read English
  • Younger than age 18

Sites / Locations

  • Butler Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Integrated Treatment Adherence Program (ITAP)

Safety Assessment and Follow-up Evaluation (SAFE)

Arm Description

A combination of in-person and phone sessions along with significant other involvement over 6 months post-hospitalization.

Enhanced symptom monitoring and safety evaluation over 6 months post-hospitalization.

Outcomes

Primary Outcome Measures

Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
The Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C) assesses depressive symptom severity. Total scores range from 0 to 27 and higher scores indicated higher symptom severity.
Clinician-Administered Rating Scale for Mania (CARS-M)
The Clinician-Administered Rating Scale for Mania (CARS-M) assesses mania symptom severity. Total scores range from 0 to 50 and higher scores indicated higher symptom severity.

Secondary Outcome Measures

Full Information

First Posted
December 16, 2019
Last Updated
October 2, 2023
Sponsor
Butler Hospital
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT04202393
Brief Title
Intervention for Comorbid Substance Use and Bipolar Disorders
Acronym
ITAP
Official Title
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Butler Hospital
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive an enhanced safety monitoring program, both provided in addition to their routine care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Disorder, Substance Use Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Integrated Treatment Adherence Program (ITAP)
Arm Type
Experimental
Arm Description
A combination of in-person and phone sessions along with significant other involvement over 6 months post-hospitalization.
Arm Title
Safety Assessment and Follow-up Evaluation (SAFE)
Arm Type
Active Comparator
Arm Description
Enhanced symptom monitoring and safety evaluation over 6 months post-hospitalization.
Intervention Type
Behavioral
Intervention Name(s)
Integrated Treatment Adherence Program (ITAP)
Intervention Description
Psychosocial support and treatment to improve treatment adherence, symptoms, and functioning.
Intervention Type
Behavioral
Intervention Name(s)
Safety Assessment and Follow-up Evaluation (SAFE)
Intervention Description
Enhanced assessment and evaluation with clinician feedback.
Primary Outcome Measure Information:
Title
Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
Description
The Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C) assesses depressive symptom severity. Total scores range from 0 to 27 and higher scores indicated higher symptom severity.
Time Frame
6 months
Title
Clinician-Administered Rating Scale for Mania (CARS-M)
Description
The Clinician-Administered Rating Scale for Mania (CARS-M) assesses mania symptom severity. Total scores range from 0 to 50 and higher scores indicated higher symptom severity.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion: Diagnosis of a bipolar-spectrum disorder Diagnosis of a substance use disorder Taking at least one mood-stabilizing medication Exclusion: Unable to speak and read English Younger than age 18
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brandon Gaudiano, PhD
Organizational Affiliation
Butler Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ivan Miller, PhD
Organizational Affiliation
Butler Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Butler Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02906
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Upload to NIMH Data Archive

Learn more about this trial

Intervention for Comorbid Substance Use and Bipolar Disorders

We'll reach out to this number within 24 hrs